David Woolfson, professor, holds the Chair in Pharmaceutics and is Head of the School of Pharmacy at Queen's University Belfast. His research interests are in polymeric drug delivery systems for transepithelial applications, bioadhesion and biomaterials, with an emphasis on facilitated controlled drug delivery through polymeric systems, where physicochemical properties of the drug may present difficulties to efficient drug release. He has contributed to the development of the marketed pharmaceutical products, Femring vaginal ring for HRT (Warner Chilcott Inc.) and Ametop for percutaneous local anaesthesia (Smith and Nephew plc). Professor Woolfson is Chair of the British Pharmacopoeia Commission and Leader of the UK Delegation to the European Pharmacopoeia (EP) Commission. He is a member of the Scientific Advisory Board of CRC Books Inc. He has published 3 books, approximately 400 scientific publications, holds several patents on drug delivery systems and biomaterials and has given numerous invited conference presentations.